Giving a third dose of COVID-19 vaccines to adults with weakened immune systems — the immunocompromised — will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.
At the meeting scheduled for July 22, the Advisory Committee on Immunization Practices will focus on the 2% to 4% of U.S. adults with weakened immune systems. These...
Here's some reassuring news for parents: Most heart problems in children with a rare inflammatory condition triggered by COVID-19 infection resolve within a few months, a new study finds.
Multisystem inflammatory syndrome in children (MIS-C) causes inflammation throughout the body, and many patients develop a range of non-respiratory symptoms such as abdominal pain, skin rashes, heart abn...
WEDNESDAY, July 7, 2021 (HealthDay News) -- COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests.
"People with conditions that compromise their immune systems exhibit a wide spectrum of antibody responses to COVID-19 vaccinatio...
THURSDAY, July 1, 2021 (HealthDay News) -- An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found — raising hopes that it could become the first medication for the serious digestive disorder.
With celiac disease, the immune system attacks the lining of the small intestine when a genetically susceptible person eats gluten ...
When a baby is born, the mother's body provides a pathway into the world, but the journey also exposes them to beneficial bacteria that live in and on their mom. But that critical exchange doesn't happen during a cesarean section delivery.
Now, researchers report that swabbing babies delivered via C-section with gauze that has been seeded with their mother's vaginal fluids delivers the sa...
FRIDAY, June 18, 2021 (HealthDay News) – A diet designed to boost brain health appears to benefit people with multiple sclerosis (MS), new research suggests.
For the study, a team from Icahn School of Medicine at Mount Sinai in New York City examined 185 people diagnosed with MS within the past five years. Each had MRI brain scans and responded to detailed questionnaires.
Researchers say an extra dose of two-dose COVID-19 vaccines may improve immune system protection for organ transplant patients, a group that's so far responded poorly to two-dose vaccines.
"Our findings suggest clinical trials are warranted to determine if transplant recipients should receive COVID-19 vaccine booster doses as standard clinical practice, similar to what is currently done w...
People who have Crohn's disease often seek to ease their symptoms by changing what they eat, and new research suggests the Mediterranean diet may be their best bet.
The study evaluated one of the commonly used diets for Crohn's disease, known as the specific carbohydrate diet (SCD), comparing it with the Mediterranean diet, which is sometimes recommended by doctors for its heart health be...
New research suggests that many people who've undergone an organ transplant do not get an immune response from COVID-19 vaccines that's strong enough to ward off a "breakthrough" infection.
In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and one heart recipient, said a research team...
A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say.
Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% take immunosuppressive drugs. Those include chemotherapy medications and steroids such as prednisone.
New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say.
Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one in 1,000 develop a condition called multisystem inflammatory syndrome in children (MIS-C) within four to six weeks.
Cora Oakley is a rough-and-tumble 4-year-old who loves gymnastics and outdoor activities, particularly if it involves bouncing on a trampoline.
It's hard to tell from looking at her that she was born without an immune system. Kids with this condition can acquire dangerous, life-threatening infections from day-to-day activities as simple as going to school or playing with friends.
A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials.
There was a "night and day difference" in the results from bimekizumab compared against two established psoriasis drugs, secukinumab (Cosentyx) and adalimumab (Humira), said Dr. Mark Lebwohl, a co-researcher in one of t...
Gene variants associated with a rare autoimmune disorder called Addison's disease have been pinpointed, according to researchers.
"By studying the single largest collection of samples from patients with Addison's disease, we've been able to carry out the first genetic study of the disease that spans the entire human genome," said study co-leader Daniel Eriksson, a researcher in the experi...
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests.
Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant -- with cells from their own blood -- two-thirds saw no worsening in their disability 10 years out.
Just over 200,000 Americans have the autoimmune disorder lupus, and minority women are at highest risk, according to a new study.
It's the first estimate of how widespread the disease is in the United States. The number comes close to reclassifying lupus as a rare disease, defined as an illness affecting 200,000 Americans or fewer, the researchers said.
Blood vessel damage and inflammation in the brains of deceased COVID-19 patients suggest the damage is not caused by the virus, but the body's immune response to it.
Researchers from the U.S. National Institutes of Health (NIH) consistently found signs of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after getting COVID-19.
Rheumatoid arthritis patients who are in remission have significantly higher body temperatures than people without the joint disease, new research shows.
The study included 32 rheumatoid arthritis patients who were in remission and a healthy "control" group of 51 people without rheumatoid arthritis, who all had thermal scans of different areas of their feet.
When the new coronavirus pandemic first began, respiratory distress immediately became the hallmark of severe COVID-19 illness. News reports focused on the inability to breathe, low oxygen saturation levels and the alarming need for ventilators.
But six months later, experts are becoming increasingly concerned about a very different COVID-19 phenomenon, one that spares the lungs only ...
Scientists knew that dangerous T-cells lived in the pancreases of people with type 1 diabetes, but a new study shows they also take up residence in the pancreases of healthy individuals.
Researchers from the La Jolla Institute for Immunology in California used a new staining technique to show where these cells had gathered in human tissue samples. They were surprised that even tissue ...
A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports.
Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD), said co-resea...
Adding a newer drug to standard therapy might help control kidney complications caused by the autoimmune disease lupus, a new clinical trial suggests.
The researchers found that adding the drug, called belimumab, improved patients' likelihood of responding to treatment. That meant a reduction in protein in the urine -- a tell-tale sign of kidney inflammation -- and no significant loss...
When actress Alyssa Milano was first struck by the new coronavirus back in March, her symptoms mirrored the classic signs of COVID-19: fever, headache, loss of smell, chest heaviness, extreme breathing difficulties and a bad stomach.
"It felt like I was dying," Milano, 47, posted on Twitter.
Those symptoms have persisted, and even expanded to include vertigo, heart palpitati...
An infusion of cells that dampen the body's immune response might help people with severe cases of the new coronavirus recover more quickly, a new report suggests.
Two patients so sick with COVID-19 that they'd been put on a ventilator improved quickly when given an infusion of regulatory T-cells, which are cells that check the immune system and prevent it from overreacting to an infe...
A blood test may predict which COVID-19 patients are likely to need a ventilator.
This finding could lead to a scoring system that would flag at-risk patients for closer monitoring and to personalized treatments. It may also help explain how diabetes makes outcomes worse, according to researchers from the University of Virginia School of Medicine.
There's new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19.
The medication, called colchicine, is an anti-inflammatory taken as a pill. It's long been prescribed for gout, a form of arthritis, and its history goes back centuries. The drug was first sourced from the autumn crocus flower.
HIV may not be the death sentence it was 20 or 30 years ago, but people who are HIV-positive still face much shorter lives than other adults -- even if they're treated with medications that make the virus undetectable.
A new study reports that people who were HIV-positive at age 21 had an average life expectancy of 56 years -- nine years fewer than their virus-free peers.
Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report.
They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels were high. In urban areas, the risk was 29% higher than in rural areas.
The severity of COVID-19 illness may be influenced by what researchers call "cytokine storms."
In a new study, investigators assessed 522 COVID-19 patients, aged 5 days to 97 years, who were admitted to two hospitals in Wuhan, China, in December and January. The study also included a "control group" of 40 healthy people.
Compared to the control group, 76% of COVID-19 pat...
Hydroxychloroquine is a key therapy for the autoimmune disease lupus, but interest in it as a potential COVID-19 treatment could make it hard for lupus patients to obtain, experts warn.
Hydroxychloroquine is the only medication known to increase survival in patients with systemic lupus. That's the most common form of lupus, a disease in which the immune system attacks different parts ...